Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2337569
Max Phase: Preclinical
Molecular Formula: C36H32N2O14
Molecular Weight: 716.65
Molecule Type: Small molecule
Associated Items:
ID: ALA2337569
Max Phase: Preclinical
Molecular Formula: C36H32N2O14
Molecular Weight: 716.65
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(CCN(C)Cc1c(O)cc(O)c2c(=O)c(O)c(-c3ccc(O)c(O)c3)oc12)Cc1c(O)cc(O)c2c(=O)c(O)c(-c3ccc(O)c(O)c3)oc12
Standard InChI: InChI=1S/C36H32N2O14/c1-37(13-17-21(41)11-25(45)27-29(47)31(49)33(51-35(17)27)15-3-5-19(39)23(43)9-15)7-8-38(2)14-18-22(42)12-26(46)28-30(48)32(50)34(52-36(18)28)16-4-6-20(40)24(44)10-16/h3-6,9-12,39-46,49-50H,7-8,13-14H2,1-2H3
Standard InChI Key: OEXOZMUYVMRYTG-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 716.65 | Molecular Weight (Monoisotopic): 716.1854 | AlogP: 3.85 | #Rotatable Bonds: 9 |
Polar Surface Area: 269.20 | Molecular Species: ACID | HBA: 16 | HBD: 10 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 10 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.80 | CX Basic pKa: 6.97 | CX LogP: 2.60 | CX LogD: 0.69 |
Aromatic Rings: 6 | Heavy Atoms: 52 | QED Weighted: 0.10 | Np Likeness Score: 0.50 |
1. Joshi D, Field J, Murphy J, Abdelrahim M, Schönherr H, Sparrow JR, Ellestad G, Nakanishi K, Zask A.. (2013) Synthesis of antioxidants for prevention of age-related macular degeneration., 76 (3): [PMID:23346866] [10.1021/np300769c] |
Source(1):